Mirae Asset Global Investments
EPZM

Mirae Asset Global Investments’s Epizyme, Inc EPZM Stock Holding History

Mirae Asset Global Investments’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,507
Closed -$27K – 2486
2022
Q1 		$27K Sell
23,507
-457
-2% -$745 ﹤0.01% 1572
2021
Q4 		$60K Buy
23,964
+574
+2% +$2.25K ﹤0.01% 1561
2021
Q3 		$120K Buy
23,390
+2,237
+11% +$13.6K ﹤0.01% 1718
2021
Q2 		$176K Buy
+21,153
New +$178K ﹤0.01% 1663

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mirae Asset Global Investments's EPZM Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 23,507 shares — an estimated $27K sold.

Mirae Asset Global Investments first reported a position in EPZM in Q2 2021 and held it in 4 quarters. The position peaked at $176K in Q2 2021. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Mirae Asset Global Investments reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 23,507 Epizyme, Inc shares in Q2 2022, an estimated $27K.
  • Mirae Asset Global Investments first reported a position in Epizyme, Inc in Q2 2021 and held it in 4 quarters.
  • Mirae Asset Global Investments's Epizyme, Inc position peaked at $176K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.